Clinical Trial Update: Study of Fish Oil to Reduce ALT Levels in Adolescents [Phase 1]

View source ↗

Summary

Phase 1 trial assessing whether fish oil can lower ALT levels in adolescents with fatty liver diseases; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Fish oil

Snippet

Sponsor: Boston University | Conditions: Non-alcoholic Fatty Liver Disease, Fatty Liver | Phase 1 | Status: TERMINATED